Research Article
The Role of Long Pentraxin 3 and Nuclear Factor Kappa Beta in Vitiligo Occurrence and Disease Severity
Table 1
Comparison of long PTX3, NF-kB, and demographic findings of both groups.
| | Vitiligo (n = 27) | Control (n = 27) | values |
| Age (years) | 39.7 ± 4,11 | 38.5 ± 3.59 | 0.12 | BMI (kg/m2) | 26.8 ± 5.30 | 26.1 ± 3.98 | 0.40 | Gender (female or male) | F: 11 | F: 11 | 0.35 | M: 16 | M: 16 | Active progressive phase | 11 | — | NA | Slow progressive phase | 16 | — | NA | Long pentraxin 3 (ng/ml) | 8.21 ± 2.11 | 6.76 ± 1.90 | <0.03 | NF-kB (ng/ml) | 15.03 ± 3.45 | 12.19 ± 4.20 | <0.01 |
| | Active progressive | Slow progressive | |
| Long pentraxin 3 (ng/ml) | 9.56 ± 3.20 | 7.10 ± 1.90 | <0.01 | NF-kB (ng/ml) | 17.3 ± 3.09 | 11.9 ± 2.07 | <0.01 |
|
|
Results are given as Mean ± SD. < .05 was considered significant. NA: not applicable. BMI: body mass index. |